FDA Inspection 1151636 — Rocky Mountain Center for Reproductive Medicine

Rocky Mountain Center for Reproductive Medicine — FEI 3003936967

The FDA completed an inspection of Rocky Mountain Center for Reproductive Medicine on July 21, 2021 in Fort Collins, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 21, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Fort Collins, CO (United States)